Fidaxomicin: a macrocyclic antibiotic for the treatment of Clostridium difficile infection.
about
A year in review: new drugs for older adults in 2011Macrocyclic drugs and synthetic methodologies toward macrocyclesProgress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review.Culturable diversity and antimicrobial activity of Actinobacteria from marine sediments in Valparaíso bay, Chile.Characterizations of clinical isolates of clostridium difficile by toxin genotypes and by susceptibility to 12 antimicrobial agents, including fidaxomicin (OPT-80) and rifaximin: a multicenter study in TaiwanIn vitro and in vivo antibacterial evaluation of cadazolid, a new antibiotic for treatment of Clostridium difficile infections.Investigations of the mode of action and resistance development of cadazolid, a new antibiotic for treatment of Clostridium difficile infections.Recent derivatives from smaller classes of fermentation-derived antibacterials.Toward revision of antimicrobial therapies in hematopoietic stem cell transplantation: target the pathogens, but protect the indigenous microbiota.Identification of Highly Specific Diversity-Oriented Synthesis-Derived Inhibitors of Clostridium difficile.Strategies for management of Clostridium difficile infection in immunosuppressed patientsFidaxomicin inhibits Clostridium difficile toxin A-mediated enteritis in the mouse ileum.MBX-500, a hybrid antibiotic with in vitro and in vivo efficacy against toxigenic Clostridium difficile.Clostridium difficile-associated diarrhea: role of the pharmacist in the health system.
P2860
Q33637890-34BD9A09-A95F-4517-B251-83CED82C53C3Q34740721-47F3700F-0609-4F38-B078-60F27A4E5FC8Q35044119-9F4B4445-E295-4B7D-A0F4-7095FA0D4364Q35748515-E22B973E-7420-440C-9E45-9452DA5B8F5FQ36086377-391FAAC8-E446-42CB-AF76-1E08BBEE3F73Q37544607-B553A2D5-3B39-46BA-AA0D-6E5563E7B5DFQ37544845-976774D3-F45D-4415-B41A-7B21340AB074Q37964009-BC902886-52CA-4763-BFD6-41E660BECEBFQ38924661-19241A54-059A-45C0-B18F-6A4A146D8C1BQ38953573-98673D34-F6D7-4615-8A6C-11BE267C8BB9Q40622201-42095E70-46F5-450D-94FF-26F11C63CC52Q41834229-2F3E4206-44BB-428C-A1ED-074CC0A59284Q42281252-5C88835D-418C-402C-A8CA-13C9ADCED4F0Q46780148-24B2BCE6-1567-4D03-B5B8-5DF75401622B
P2860
Fidaxomicin: a macrocyclic antibiotic for the treatment of Clostridium difficile infection.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Fidaxomicin: a macrocyclic ant ...... ostridium difficile infection.
@en
Fidaxomicin: a macrocyclic ant ...... ostridium difficile infection.
@nl
type
label
Fidaxomicin: a macrocyclic ant ...... ostridium difficile infection.
@en
Fidaxomicin: a macrocyclic ant ...... ostridium difficile infection.
@nl
prefLabel
Fidaxomicin: a macrocyclic ant ...... ostridium difficile infection.
@en
Fidaxomicin: a macrocyclic ant ...... ostridium difficile infection.
@nl
P2860
P356
P1433
P1476
Fidaxomicin: a macrocyclic ant ...... ostridium difficile infection.
@en
P2093
Jennifer S Hardesty
Paul Juang
P2860
P304
P356
10.1592/PHCO.31.9.877
P407
P577
2011-09-01T00:00:00Z